CAI FY 2010 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$78M+19.4% YoY

Gross Profit

$72M92.1% margin

Operating Income

$37M47.5% margin

Net Income

$28M36.4% margin

EPS (Diluted)

$1.56

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

-$164M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$613M

Total Liabilities

$416M

Stockholders' Equity

$180M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$65M	+19.4%
Gross Profit	$72M	$57M	+26.8%
Operating Income	$37M	$23M	+61.9%
Net Income	$28M	$14M	+109.4%